Amgen (AMGN) has reached a settlement with the FTC that will allow the company to move forward with its takeover of Horizon Therapeutics (HZNP) after accepting a binding deal that the combined company will bundle together some of its drugs.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMGN:
- Horizon Therapeutics (NASDAQ:HZNP) Gains after FTC Settlement
- AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
- Biden unveils first 10 drugs subject to Medicare price negotiation
- Amgen-Horizon Deal: FTC Pauses Proceedings to Block Acquisition
- FTC pauses challenge to Amgen deal for Horizon Therapeutics, WSJ reports